It is indicated in the US for the treatment of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia in addition to fibromyalgia.
It is not currently approved for the treatment of postoperative pain
The studies were intended to support potential registration in the US
The efficacy and safety of pregabalin in the treatment of post‐surgical pain were evaluated in 2 separate clinical trials: – Post‐total knee arthroplasty (post‐TKA) ClinicalTrials.gov
identifier: NCT00442546, Post‐inguinal hernia repair (post‐IHR) ClinicalTrials.gov identifier: NCT00551135
